Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling

1 Jan 2021

Abstract excerpt

Altogether, our study reveals that patient stratification according to immune subtypes, HLA status, and immune checkpoint molecule quantification should be considered prior to immune checkpoint inhibitor therapy. Moreover, TIM-3 protein should be considered an axis for future therapeutic development.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CNS Lymphoma Diagnosis and Treatment
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33664848
DOI: 10.7150/thno.54343

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signalingPMID 33664848Read ↗

Single-cell landscape of primary central nervous system diffuse large B-cell lymphomaSemantic proximity Read ↗

Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphomaSemantic proximity Read ↗

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell LymphomaSemantic proximity Read ↗

Pathology and new insights in central nervous system lymphomas.Semantic proximity Read ↗

Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphomaSemantic proximity Read ↗

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapySemantic proximity Read ↗

The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.Semantic proximity Read ↗

Optimizing therapy for nodal marginal zone lymphomaSemantic proximity Read ↗

Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSLSemantic proximity Read ↗

Transcriptomic profiling of an in vivo diffuse large B-cell lymphoma model reveals molecular programs underlying CNS disseminationSemantic proximity Read ↗

Tumoral immune microenvironment profiling in B-cell non-Hodgkin lymphoma stratifies patients in different prognostic groups.Semantic proximity Read ↗

miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.